Development of the polymer micelle carrier system for doxorubicin - PubMed (original) (raw)
Development of the polymer micelle carrier system for doxorubicin
T Nakanishi et al. J Control Release. 2001.
Abstract
We show the result of pre-clinical study of NK911, a polymeric micelle carrier system for doxorubicin (DOX). The NK911 micelle carrier consists of polyethyleneglycol and conjugated doxorubicin-polyaspartic acid. It has high hydrophobic inner core, and therefore can entrap the sufficient amount of DOX. NK911 has a small particle size of about 40 nm in diameter that accumulates in tumor tissue by EPR effect showing much stronger activity than the free DOX. We plan to perform a clinical trial at National Cancer Center Hospital, Japan from 2001.
Similar articles
- Significant enhancement of antitumor activity and bioavailability of intracellular pH-sensitive polymeric micelles by folate conjugation.
Bae Y, Kataoka K. Bae Y, et al. J Control Release. 2006 Nov 28;116(2):e49-50. doi: 10.1016/j.jconrel.2006.09.044. J Control Release. 2006. PMID: 17718965 No abstract available. - Polymeric micelle drug carrier systems: PEG-PAsp(Dox) and second generation of micellar drugs.
Nishiyama N, Kataoka K. Nishiyama N, et al. Adv Exp Med Biol. 2003;519:155-77. doi: 10.1007/0-306-47932-X_10. Adv Exp Med Biol. 2003. PMID: 12675214 Review. No abstract available. - Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice.
Gao ZG, Lee DH, Kim DI, Bae YH. Gao ZG, et al. J Drug Target. 2005 Aug;13(7):391-7. doi: 10.1080/10611860500376741. J Drug Target. 2005. PMID: 16308207 Free PMC article. - Preparation of core cross-linked PCL-PEG-PCL micelles for doxorubicin delivery in vitro.
Zhang J, Men K, Gu Y, Wang X, Gou M, Guo G, Luo F, Qian Z. Zhang J, et al. J Nanosci Nanotechnol. 2011 Jun;11(6):5054-61. doi: 10.1166/jnn.2011.4121. J Nanosci Nanotechnol. 2011. PMID: 21770143 - Multifunctional micelle delivery system for overcoming multidrug resistance of doxorubicin.
Qin L, Wu L, Jiang S, Yang D, He H, Zhang F, Zhang P. Qin L, et al. J Drug Target. 2018 Apr;26(4):289-295. doi: 10.1080/1061186X.2017.1379525. Epub 2017 Sep 21. J Drug Target. 2018. PMID: 28901798 Review.
Cited by
- Enhanced intercellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells.
Mohajer G, Lee ES, Bae YH. Mohajer G, et al. Pharm Res. 2007 Sep;24(9):1618-27. doi: 10.1007/s11095-007-9277-5. Epub 2007 Mar 24. Pharm Res. 2007. PMID: 17385015 - Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action.
Adhikari HS, Yadav PN. Adhikari HS, et al. Int J Biomater. 2018 Dec 30;2018:2952085. doi: 10.1155/2018/2952085. eCollection 2018. Int J Biomater. 2018. PMID: 30693034 Free PMC article. Review. - Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin.
Liu CW, Lin WJ. Liu CW, et al. Int J Nanomedicine. 2012;7:4749-67. doi: 10.2147/IJN.S32830. Epub 2012 Aug 29. Int J Nanomedicine. 2012. PMID: 22973097 Free PMC article. - Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution.
Callahan DJ, Liu W, Li X, Dreher MR, Hassouneh W, Kim M, Marszalek P, Chilkoti A. Callahan DJ, et al. Nano Lett. 2012 Apr 11;12(4):2165-70. doi: 10.1021/nl300630c. Epub 2012 Mar 19. Nano Lett. 2012. PMID: 22417133 Free PMC article. - Clinical Translation of Nanomedicine.
Min Y, Caster JM, Eblan MJ, Wang AZ. Min Y, et al. Chem Rev. 2015 Oct 14;115(19):11147-90. doi: 10.1021/acs.chemrev.5b00116. Epub 2015 Jun 19. Chem Rev. 2015. PMID: 26088284 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources